EP4404857A4 - CONTROLLED INJURY AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY - Google Patents

CONTROLLED INJURY AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY

Info

Publication number
EP4404857A4
EP4404857A4 EP22870831.9A EP22870831A EP4404857A4 EP 4404857 A4 EP4404857 A4 EP 4404857A4 EP 22870831 A EP22870831 A EP 22870831A EP 4404857 A4 EP4404857 A4 EP 4404857A4
Authority
EP
European Patent Office
Prior art keywords
electric field
immune response
pulsed electric
field therapy
controlled lesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22870831.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4404857A1 (en
Inventor
Timothy J O'brien
William S Krimsky
Matthew T Silvestrini
Chiara Pastori
Robert E Ii Neal
Jonathan R Waldstreicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galvanize Therapeutics Inc
Original Assignee
Galvanize Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galvanize Therapeutics Inc filed Critical Galvanize Therapeutics Inc
Publication of EP4404857A1 publication Critical patent/EP4404857A1/en
Publication of EP4404857A4 publication Critical patent/EP4404857A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206—Generators therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00613—Irreversible electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14—Probes or electrodes therefor
    • A61B2018/1405—Electrodes having a specific shape
    • A61B2018/1425—Needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Surgical Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
EP22870831.9A 2021-09-20 2022-09-19 CONTROLLED INJURY AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY Pending EP4404857A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163246239P 2021-09-20 2021-09-20
US202163290529P 2021-12-16 2021-12-16
US202263322319P 2022-03-22 2022-03-22
US202263351562P 2022-06-13 2022-06-13
PCT/US2022/044021 WO2023044124A1 (en) 2021-09-20 2022-09-19 Controlled lesion and immune response to pulsed electric field therapy

Publications (2)

Publication Number Publication Date
EP4404857A1 EP4404857A1 (en) 2024-07-31
EP4404857A4 true EP4404857A4 (en) 2025-07-16

Family

ID=85603549

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22870831.9A Pending EP4404857A4 (en) 2021-09-20 2022-09-19 CONTROLLED INJURY AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY

Country Status (5)

Country Link
EP (1) EP4404857A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024534500A (cg-RX-API-DMAC7.html)
AU (1) AU2022348518A1 (cg-RX-API-DMAC7.html)
CA (1) CA3233052A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023044124A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474760B1 (en) 2016-06-27 2023-01-11 Galvanize Therapeutics, Inc. Generator and a catheter with an electrode for treating a lung passageway
US12564440B2 (en) 2021-04-26 2026-03-03 Pulse Biosciences, Inc. Multi-strut ablation and sensing catheter devices and methods
CA3215962A1 (en) 2021-04-26 2022-11-03 Roman Turovskiy Circumferential ablation devices and methods
US12446944B2 (en) 2021-04-26 2025-10-21 Pulse Biosciences, Inc. Mapping and ablation applicators
WO2025043024A2 (en) * 2023-08-22 2025-02-27 Galvanize Therapeutics, Inc. Quantification of immunological status and treatment planning
JP2025050034A (ja) * 2023-09-22 2025-04-04 日本ライフライン株式会社 電源装置およびアブレーションシステム
CN117982802B (zh) * 2024-04-07 2024-06-18 浙江大学 一种闭环肺部肿瘤电场治疗系统

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020061192A1 (en) * 2018-09-18 2020-03-26 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
WO2020215007A1 (en) * 2019-04-18 2020-10-22 Galary, Inc. Devices, systems and methods for the treatment of abnormal tissue
US20200398048A1 (en) * 2017-12-26 2020-12-24 Galary, Inc. Optimization of energy delivery for various applications
WO2021011733A1 (en) * 2019-07-16 2021-01-21 Galary, Inc. Treatment of the reproductive tract with pulsed electric fields
US20210146126A1 (en) * 2017-12-26 2021-05-20 Galary, Inc. Methods, apparatuses, and systems for the treatment of disease states and disorders
WO2021127558A1 (en) * 2019-12-18 2021-06-24 Galary, Inc. Treatment of cardiac tissue with pulsed electric fields
WO2021207385A1 (en) * 2020-04-08 2021-10-14 Galary, Inc. Pulsed electric field waveform manipulation and use
WO2023172773A1 (en) * 2022-03-11 2023-09-14 Virginia Tech Intellectual Properties, Inc. Systems and methods of using pulsed electric fields to spatially control cell death mechanisms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0810066A2 (pt) * 2007-04-19 2015-05-05 The Foundry Inc Sistemas e métodos para criação de um efeito utilizando energia de microondas à tecido específico
WO2015085162A1 (en) * 2013-12-05 2015-06-11 Rfemb Holdings, Llc Cancer immunotherapy by radiofrequency electrical membrane breakdown (rf-emb)
US11311329B2 (en) * 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
EP4065005A4 (en) * 2019-11-27 2023-12-27 North Carolina State University METHOD FOR CONTROLLING TREATMENT VOLUME, HEAT GRADIENTS, MUSCLE STIMULATION AND IMMUNE RESPONSES IN PULSED ELECTRICAL FIELD TREATMENTS

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200398048A1 (en) * 2017-12-26 2020-12-24 Galary, Inc. Optimization of energy delivery for various applications
US20210146126A1 (en) * 2017-12-26 2021-05-20 Galary, Inc. Methods, apparatuses, and systems for the treatment of disease states and disorders
WO2020061192A1 (en) * 2018-09-18 2020-03-26 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
WO2020215007A1 (en) * 2019-04-18 2020-10-22 Galary, Inc. Devices, systems and methods for the treatment of abnormal tissue
WO2021011733A1 (en) * 2019-07-16 2021-01-21 Galary, Inc. Treatment of the reproductive tract with pulsed electric fields
WO2021127558A1 (en) * 2019-12-18 2021-06-24 Galary, Inc. Treatment of cardiac tissue with pulsed electric fields
WO2021207385A1 (en) * 2020-04-08 2021-10-14 Galary, Inc. Pulsed electric field waveform manipulation and use
WO2023172773A1 (en) * 2022-03-11 2023-09-14 Virginia Tech Intellectual Properties, Inc. Systems and methods of using pulsed electric fields to spatially control cell death mechanisms

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023044124A1 *

Also Published As

Publication number Publication date
WO2023044124A1 (en) 2023-03-23
CA3233052A1 (en) 2023-03-23
JP2024534500A (ja) 2024-09-20
EP4404857A1 (en) 2024-07-31
AU2022348518A1 (en) 2024-04-04

Similar Documents

Publication Publication Date Title
EP4404857A4 (en) CONTROLLED INJURY AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY
US9867996B2 (en) Methods and systems for skin treatment
MX2023006353A (es) Sistema ultravioleta para el tratamiento intracorporal.
MX386896B (es) Composiciones y el uso de las mismas para incrementar la inmunidad terapéutica reduciendo selectivamente los monocitos m2 inmunomoduladores.
EP3655961A4 (en) HEALTHY AND SICK BARRIER TISSUE CELL ATLAS
MX2016009809A (es) Polipéptidos efectores de la subunidad a de la toxina shiga desinmunizada para aplicaciones en mamíferos.
CY1121838T1 (el) Συνθεσεις που περιλαμβανουν νανοσωματιδια οξειδιου του αφνιου (iv) ή οξειδιου του ρηνιου (iv) σε συνδυασμο με ιονιζουσες ακτινοβολιες για αντιμετωπιση καρκινου
JP2012179385A5 (cg-RX-API-DMAC7.html)
EA201391328A1 (ru) Многофункциональный катетер
BR112017027897A2 (pt) usos terapêuticos das formulações de berberina
JP2015527177A5 (ja) 皮膚科医療装置
EP3411481A4 (en) TREATMENT OF DISEASES ASSOCIATED WITH ANGIOGENESIS USING ANGPT2 AND PDGFB TARGETED RNA COMPLEXES
EA201690021A1 (ru) Алкалоидные композиции из вида ribes для лечения состояний, связанных с функцией митохондрий или ингибированием pde4, pde5 и ikk-бета
Sotoudeh et al. The influence of low-level laser irradiation on spinal cord injuries following ischemia-reperfusion in rats
EP3843765A4 (en) THERAPEUTIC COMBINATIONS OF BOSWELLIA EXTRACT AND CANNABINOIDS
Lawson Copper-quercetin complexes: methods of study, relevance to cell death pathways, therapeutic applications
CL2020001791A1 (es) Composiciones farmacéuticas para la piel tópicas que contienen cerdulatinib y usos de estas.
BR112018008359A2 (pt) método para o tratamento térmico de tecidos biológicos
MX393477B (es) Combinación de vorasidenib con radiación y/o agentes adicionales para tratar gliomas.
Aparicio-Salcedo et al. Eficacia farmacológica del aloe vera en la cicatrización de heridas: Una revisión narrativa
EP4543290A4 (en) THERAPEUTIC ELECTRICAL MUSCLE STIMULATION DEVICE AND TREATMENT METHOD
MX393475B (es) Uso de una combinación de ivosidenib y radiación para tratar gliomas.
ES2754222T3 (es) Procedimiento para el tratamiento cosmético de la piel
Sadoughi et al. The effec of shoots of Allium sativum L., Ferula assa-foetida aqueous extract and low frequency electromagnetic field on angiogenesis in chick chorioallantoic membrane (in vivo)
Soeprijanto et al. Mechanism of increasing of HSP-70 on irradiated rat breast cancer, due to application of extract of Phyllanthus niruri.

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20250616

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 18/14 20060101AFI20250610BHEP

Ipc: A61K 39/395 20060101ALI20250610BHEP

Ipc: A61P 35/04 20060101ALI20250610BHEP

Ipc: C07K 16/28 20060101ALI20250610BHEP

Ipc: A61P 35/00 20060101ALI20250610BHEP

Ipc: A61B 18/12 20060101ALN20250610BHEP

Ipc: A61B 18/00 20060101ALN20250610BHEP

Ipc: A61K 39/00 20060101ALN20250610BHEP